Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-061197
Filing Date
2006-11-02
Accepted
2006-11-02 13:38:35
Documents
1
Period of Report
2006-10-31

Document Format Files

Seq Description Document Type Size
1 GILEAD FORM 4 IPO CLOSING (10/31/06) rrd134438.html 4  
1 GILEAD FORM 4 IPO CLOSING (10/31/06) rrd134438.xml 4 7955
  Complete submission text file 0001181431-06-061197.txt   9849
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Reporting) CIK: 0000882095 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 061181823
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 1003 WEST SEVENTH ST SUITE 401 FREDERICK MD 21701 3016968889
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations